← Back to Search

Baclofen for Post-Surgical Pain

Phase 4
Recruiting
Led By Mark Mandabach, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients (age >= 19 y.o.) scheduled for kidney stone-related surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 hours post-operatively to 24 hours post-operatively
Awards & highlights

Summary

This trial will test whether a common muscle relaxer can help reduce painkiller use after surgery.

Who is the study for?
This trial is for adults aged 19 or older who are scheduled for kidney stone surgery. It's not suitable for those allergic to baclofen or with conditions that could affect their ability to report and manage post-surgery pain, such as severe psychiatric disorders or language barriers.Check my eligibility
What is being tested?
The study is testing if a single oral dose of baclofen (10mg) can reduce the need for opioids after surgery. Participants will either receive baclofen or a placebo without knowing which one they're getting.See study design
What are the potential side effects?
Baclofen may cause side effects like drowsiness, weakness, dizziness, headache, seizures, nausea, and confusion. Not everyone will experience these side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 19 or older and scheduled for kidney stone surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 hours post-operatively to 24 hours post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 0 hours post-operatively to 24 hours post-operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative Opioid Requirements

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Opioid Tolerant - baclofenExperimental Treatment1 Intervention
Group II: Opioid Naive - baclofenExperimental Treatment1 Intervention
Group III: Opioid Naive - placeboPlacebo Group1 Intervention
Group IV: Opioid Tolerant - placeboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Baclofen
FDA approved

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,599 Previous Clinical Trials
2,287,834 Total Patients Enrolled
15 Trials studying Pain
6,997 Patients Enrolled for Pain
Mark Mandabach, MDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Baclofen 10mg Clinical Trial Eligibility Overview. Trial Name: NCT03720717 — Phase 4
Pain Research Study Groups: Opioid Naive - placebo, Opioid Tolerant - baclofen, Opioid Tolerant - placebo, Opioid Naive - baclofen
Pain Clinical Trial 2023: Baclofen 10mg Highlights & Side Effects. Trial Name: NCT03720717 — Phase 4
Baclofen 10mg 2023 Treatment Timeline for Medical Study. Trial Name: NCT03720717 — Phase 4
~15 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top